10x Genomics, Inc. · NASDAQ:TXG
Saxonov Serge sold 30,000 10x Genomics, Inc. shares (Form 4)
Traded Jun 22, 2026 · Filed Jun 24, 2026
On Jun 22, 2026, Saxonov Serge (Director, Chief Executive Officer) sold 30,000 10x Genomics, Inc. shares at an average US$34.44 for US$1.03M under a trading plan, leaving 1,108,380 shares. Filed Jun 24, 2026 (Form 4).
- Sold
- 30,000 shares
- Price
- US$34.44 average (US$33.29 to US$36.16)
- Value
- US$1.03M
- Holding after
- 1,108,380 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Class A Common Stock | Sale | 8,527 | US$33.29 | 1,129,853 | Direct |
| Jun 22, 2026 | Class A Common Stock | Sale | 9,991 | US$34.28 | 1,119,862 | Direct |
| Jun 22, 2026 | Class A Common Stock | Sale | 9,821 | US$35.32 | 1,110,041 | Direct |
| Jun 22, 2026 | Class A Common Stock | Sale | 1,661 | US$36.16 | 1,108,380 | Direct |
Source
Related
- 10x Genomics, Inc.
- Saxonov Serge
- 10x Genomics, Inc. shareholders
- Form 4 · Saxonov Serge · Sep 24, 2026
- Form 4 · Saxonov Serge · Sep 3, 2026
- Form 4 · Saxonov Serge · Aug 28, 2026
- Form 4 · Saxonov Serge · Aug 26, 2026
- Form 4 · Saxonov Serge · Aug 24, 2026
- Schedule 13G/A · ARK Investment Management LLC · Oct 7, 2026
- Form 4 · Suliman Shehnaaz · Sep 24, 2026
- Form 4 · Taich Adam · Sep 11, 2026
- Form 4 · Stuelpnagel John R · Sep 8, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Sep 8, 2026